Source: DGNews | Posted 8 years ago
Adjuvant Therapy with Oxaliplatin Increases Disease-Free Colorectal Cancer Survival
Tags:
By Ed Susman
CHICAGO, IL -- June 2, 2003 -- Use of the anticancer drug oxaliplatin in the adjuvant setting results in a 23% reduction in risk of relapse from colorectal cancers, according to a study in Europe.
The researchers presented the findings here June 1st at the 39th Annual Meeting of the American Society of Clinical Oncology (ASCO).
"We are very encouraged by these results and expect that they will change the standard of care for many patients with colorectal cancer," said Aimery de Gramont, MD, a medical oncologist at H
Comments